首页 | 官方网站   微博 | 高级检索  
     

冠状动脉搭桥术后再狭窄与反义基因的治疗
引用本文:张谦,单岩,杨栋.冠状动脉搭桥术后再狭窄与反义基因的治疗[J].医药论坛杂志,2003,24(19):15-16,18.
作者姓名:张谦  单岩  杨栋
作者单位:1. 郑州大学第一附属医院小儿外科,郑州市,450052
2. 郑州大学护理学院,450052
摘    要:冠状动脉搭桥手术失败的主要原因是静脉移植物的再狭窄。其中心环节是血管平滑肌细胞(VSMC)增生。抑制VSMC的增生以预防静脉移植物的再狭窄是目前心血管研究的热点。本文就反义基因预防静脉移植物再狭窄的原理、优点、反义核酸的设计、反义治疗中必须考虑的问题进行阐述,探讨在分子水平预防冠脉搭桥术的再狭窄的有效方法。

关 键 词:冠状动脉搭桥术  术后再狭窄  反义基因  治疗  静脉移植物

Restenosis after Coronary Bypass Grafting and Therapy of Antisense Gene
Zhang Qian,Shan Yan,Yang Dong.Restenosis after Coronary Bypass Grafting and Therapy of Antisense Gene[J].Journal of Medical Forum,2003,24(19):15-16,18.
Authors:Zhang Qian  Shan Yan  Yang Dong
Abstract:Saphenous vein graft occlusion is a main reason for the failure of coronary bypass grafting.Vascular smooth muscle cell(VSMC)hyperplasis is a pivotal component of this pathobiology.it is a hot pog that VSMC proliferation is inhibited in order to prevent the restenosis of vein grafts.In this study,we discussed the principles,virtues,antisense oligodioxynucleotides' design,relative problems about inhibiting to the restenosis of vein grafts by antisense gene so that we investingate an effective method to prohibite restenosis after coronary bypass grafting.
Keywords:Saphenou vein graft  antisense gene  restenosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号